Cell strain capable of multiplying an Epstein-Barr virus
AssigneeHitachi Chemical Company, Ltd.
InventorsKenzo Takada, Akiko Tochikura, Mitsuo Yamaki
Life of this patent
Estimating the term…
Abstract
The present invention relates to a cell strain capable of separating and multiplying an EB virus and derived from human lymphocyte cancer cells and a method of separating and multiplying the EB virus by means of said cell strain. The present cell strain can be applied to the separation and multiplication of the wild type virus present in various places, as well as to the separation and multiplication of the virus produced by homologous recombination etc. The virus newly separated and multiplied can be applied to vaccine etc. For the more efficient separation and multiplication of the virus, several markers can be inserted into the present cell strain.
Claims2
A cell line which is deposited under the accession number FERM BP-4742.
A cell line comprising cells having all of the identifying characteristics of cells of the cell line deposited as FERM BP4742.
Dependencies are inferred from the claim text.